They found that SHARPIN mRNA expression levels are significantly elevated in invasive ductal breast carcinomas compared to non-tumor breast tissues and that the expression of this gene has an ability to discriminate breast tumors from non-tumor tissues (AUC = 0.83) [36]. This evidence concerns the gene SHARPIN and neoplasm.